Approval · Notice of Compliance 18813 · 2016
TEVA-LOPERAMIDE: Notice of Compliance 18813
Issued December 23, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18813
- Date
- December 23, 2016
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Pruduct name change and updates to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-LOPERAMIDE | 02132591 | Marketed |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB